Quick Enquire

Pharmaceutical Intermediates

Intermediate
We are the leading manufacturer & exporter of a broad ranger of pharmaceutical intermediates which are extensively used in various pharmaceutical companies & research laboratories. Using high quality chemicals these intermediates are manufactured which ensure efficacy and no side effect on human health. We offer standard as well as customized packaging on these products to exactly meet the users requirements specifications.
Intermediate
Intermediate Name Structure Code CAS Number API/ END USE
N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate DPPO-3 107688-86-8 Atomoxetine
(R)-3-Amino-piperidine dihydrochloride CNOP-6 334618-23-4 Alogliptin Linagliptin Trelagliptin
(R)-3-(Boc-Amino)piperidine BCN-4 309956-78-3 Alogliptin Linagliptin Trelagliptin
2-(Chloromethyl)-4-methylquinazoline CMQ-1 109113-72-6 Alogliptin Linagliptin Trelagliptin
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine BBX-2 666816-98-4 Alogliptin Linagliptin Trelagliptin
3-(Dimethylamino)-1-(naphthalen-1-yl)propan-1-one hydrochloride BDQ-1 5409-58-5 Bedaquiline
3-Benzyl-6-bromo-2-methoxyquinoline BBM-3 654655-69-3 Bedaquiline
Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate DAM-3 3543-72-4 Bendamustine
Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate DAM-4 3543-73-5 Bendamustine
5-iodo-2-methylbenzoic acid IMB-1 54811-38-0 Canagliflozin
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene ICG-2 898566-17-1 Canagliflozin
2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone CDE-1 32384-65-9 Canagliflozin
Dapagliflozin
Empagliflozin
4-chloro-6,7-dimethoxyquinoline CAB-4 35654-56-9 Cabozantinib
4- Guanidinobenzoic Acid HCl GBA HCl 42823-46-1 Camostat mesylate
2-Chloro-N,N-dimethylacetamide CST-1 2675-89-0 Camostat mesylate
4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester CST-2 59721-16-3 Camostat mesylate
3-(3-Trifluoromethylphenyl)propionic Acid TPA-2 585-50-2 Cinacalcet
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide CNC 1005450-55-4 Cinacalcet
4-(4-Chlorophenyl)-1H-benzo[D][1,2]oxazin-1-one CLT-1 2224-83-1 Chlorthalidone
3-(4'-chlorophenyl) phthalimidine CLT-2 2224-77-3 Chlorthalidone
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene BDG-2 461432-23-5 Dapagliflozin
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene IDG-2 1103738-29-9 Dapagliflozin
N-(2-Hydroxyethyl) succinimide HDS-1 18190-44-8 Diroximel fumarate
3,4-Dibenzyloxybenzaldehyde DBZ 5447-02-09 Droxidopa
2-ethoxybenzo[d][1,3]dioxole-5-carbaldehyde DXP-1 1638296-86-2 Droxidopa
Ethyl 3(-4-(ethyl amino)-3- nitro-N-(pyridin-2-yl)benzamido)propanoate DG-2 429659-01-8 Dabigatran
Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate CBA-3G 212322-56-0 Dabigatran
2-(4-Cyanophenylamino) Acetic Acid CBA-4 42288-26-6 Dabigatran
Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate. DBG-1 211915-84-3 Dabigatran
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride. DBG-2 211914-50-0 Dabigatran
ethyl 3-[[2-(chloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate DAB-1 1307233-94-8 Dabigatran
Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoate DAB-2 211915-06-9 Dabigatran
Hexyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride NAR-2 1307233-93-7 Dabigatran
2-(N-BOC)-Aminothiazole-5-carboxylic acid DTB-3 302964-02-9 Dasatinib
(E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide ATC-2 863127-76-8 Dasatinib
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide ATC-3 302964-24-5 Dasatinib
4,6-dichloro-2-methylpyrimidine PMD-2 1780-26-3 Dasatinib
N-Boc-D-phenyl glycinol RPG-2 102089-74-7 Elagolix
(R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate RPG-3 102089-75-8 Elagolix
2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde DBD 29668-44-8 Eliglustat
(S)-(+)-2-Phenylglycinol ELG 20989-17-7 Eliglustat
5-Bromo-2-chlorobenzoic acid BEB-3 21739-92-4 Empagliflozin
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran BEG-3 915095-89-5 Empagliflozin
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran IEG-3 915095-94-2 Empagliflozin
6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one ENS-4 76536-66-8 Ensifentrine
3-(N-Methyl-N-Pentyl amino)propionic acid HCl IBA3 625120-81-2 Ibandronate
4-Aminopyrazolo[3,4-d]pyrimidine IBT-3P 2380-63-4 Ibrutinib
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine PPA-2 330786-24-8 Ibrutinib
(ethane-1,2-diylbis(oxy)) bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) ICT-1 19249-03-7 Icotinib
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride MPB-2 106261-49-8 Imatinib
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine IMA-5 152460-10-1 Imatinib
Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate IVF-2 52980-28-6 Ivacaftor
4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 33616) IVF-3P 13721-01-2 Ivacaftor
5-Amino-2,4-ditert-butylphenol ABT-3 873055-58-4 Ivacaftor
5-Amino-2,4-ditert-butylphenol hydrochloride ABT-4 1777786-05-6 Ivacaftor
2-bromo-1-(2,4-dichlorophenyl)ethanone DCA 2631-72-3 Levoketocazole
(S)-4-Chloromethyl-2,2-dimethyl-1,3-dioxolane SKL 60456-22-6 Levoketocazole
4-Chloro-1-(4-fluorophenyl)butan-1-one LMT-1 3874-54-2 Lumateperone
2-(2-Aminothiazol-4-yl)acetic acid ATA-2 29676-71-9 Mirabegron
2-(2-Aminothiazol-4-yl)acetic acid hydrochloride ATA-2 HCL 66659-20-9 Mirabegron
2-(4-nitrophenyl)ethanamine hydrochloride MRG-2 29968-78-3 Mirabegron
(R)-2-(4-nitrophenethylamino)-1- Phenylethanol (USDMF No 35841 ) MRG-4 BASE 223673-34-5 Mirabegron
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride MRG-4 521284-21-9 Mirabegron
(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol MRG-5 BASE 391901-45-4 Mirabegron
(R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride MRG-5 521284-22-0 Mirabegron
N-Hydroxycytidine acetonide ester MLP-1 2346620-55-9 Molnupiravir
1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one MCZ 27387-31-1 Ondansetron
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride MAN 119812-29-2 Ondansetron
L-Glutamic acid diethyl ester hydrochloride GDE 1118-89-4 Pemetrexed disodium
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid PEM-7 137281-39-1 Pemetrexed disodium
4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride PRSI-4 84163-13-3 Paliperidone Risperidone
4-[2,4-Difluoro benzoyl]Piperidine hydrochloride PLP-2H 106266-04-0 Paliperidone Risperidone
3-(Benzyloxy)pyridine-2-amine POL-1 24016-03-3 Paliperidone Risperidone
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one SPR2Base 63234-80-0 Paliperidone Risperidone
2-Benzyl acrylic acid RAC-2 5669-19-2 Racecadotril
Benzyl glycinate p-toluene sulfonate RAC-3 1738-76-7 Racecadotril
3-Amino-6-methoxy pyridazine AMP-2 7252-84-8 Relugolix
Isonipecotamide /4-Piperidinecarboxamide INA 39546-32-2 Revefenacin
Phenyl phenylcarbamate RPT-1 4930-03-4 Ripretinib
(R)-4-chloro-N-(2-hydroxy-3-(4-(3-oxomorpholino)phenylamino)propyl) cyclopenta-1,3- dienecarboxamide RIV-3 721401-53-2 Rivaroxaban
2-[(2S)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione RXB-1 1369969-44-7 Rivaroxaban
2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione RXB-2 446292-08-6 Rivaroxaban
(S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride RXB-3 898543-06-1 Rivaroxaban
Methane sulfonamide CMS-1 3144-09-0 Selexipag
4-(Isopropylamino)butan-1-ol BBA-2 42042-71-7 Selexipag
1,2,4-Triazolo[4,3-a]pyrazine, 5,6,7,8-tetrahydro-3-(trifluoromethyl) hydrochloride DST 762240-92-6 Sitagliptin
4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one SITA-2 764667-65-4 Sitagliptin
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine SITA-3 767340 -03 -4 Sitagliptin
3-Quinuclidinone hydrochloride RCN-2 1193-65-3 Solifenacin
4-[2-hydroxyethyl]phenol TRS-2 501-94-0 Tyrosol
4-chloro-7H-pyrrolo [2,3-d]pyrimidine ITF-3 3680-69-1 Tofacitinib Barcitinib Ruxolitinib
4-Bromo-7H pyrrolo[2,3D]pyrimidine ITB-3 889939-42-8 Tofacitinib Barcitinib Ruxolitinib
2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine TDC 90213-66-4 Tofacitinib Barcitinib Ruxolitinib
3-Cyclopentylacrylonitrile CPA 591769-05-0 Tofacitinib Barcitinib Ruxolitinib
1,4,7-Trimethyl-1,4,7-Triazacyclononane TMT4 96556-05-7 Others
BOC-L-Glutamine NBG 13726-85-7 Others
(S)-Dimethyl 2-((tert-butoxycarbonyl)amino)pentanedioate BGM-2 59279-60-6 Others
1-Methylpiperidine-4-carboxamide MPC-2 62718-28-9 Others
1-methylpiperidine-4-carbonitrile MPC-3 20691-92-3 Others
(1-Methylpiperidin-4-yl)Methanamine MPC-4 7149-42-0 Others

Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country.

Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer. Mail to: marketing@arlifesciences.com